OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The gut-liver axis in liver disease: Pathophysiological basis for therapy
Agustı́n Albillos, Andrea De Gottardi, María Rescigno
Journal of Hepatology (2019) Vol. 72, Iss. 3, pp. 558-577
Open Access | Times Cited: 1390

Showing 1-25 of 1390 citing articles:

Liver cirrhosis
Pere Ginès, Aleksander Krag, Juan G. Abraldeṣ, et al.
The Lancet (2021) Vol. 398, Iss. 10308, pp. 1359-1376
Closed Access | Times Cited: 942

Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
Natascha Roehlen, Émilie Crouchet, Thomas F. Baumert
Cells (2020) Vol. 9, Iss. 4, pp. 875-875
Open Access | Times Cited: 841

Childhood and Adolescent Obesity: A Review
Alvina R. Kansra, Sinduja Lakkunarajah, M. Susan Jay
Frontiers in Pediatrics (2021) Vol. 8
Open Access | Times Cited: 368

Gut-liver axis: Pathophysiological concepts and clinical implications
Herbert Tilg, Timon E. Adolph, Michael Trauner
Cell Metabolism (2022) Vol. 34, Iss. 11, pp. 1700-1718
Open Access | Times Cited: 353

Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders
Daniel M. Chopyk, Arash Grakoui
Gastroenterology (2020) Vol. 159, Iss. 3, pp. 849-863
Open Access | Times Cited: 315

Intestinal Barrier in Human Health and Disease
Natalia Di Tommaso, Antonio Gasbarrini, Francesca Romana Ponziani
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 23, pp. 12836-12836
Open Access | Times Cited: 314

The systemic inflammation hypothesis: Towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis
Vicente Arroyo, Paolo Angeli, Richard Moreau, et al.
Journal of Hepatology (2020) Vol. 74, Iss. 3, pp. 670-685
Open Access | Times Cited: 312

Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review
Federica Di Vincenzo, Angelo Del Gaudio, Valentina Petito, et al.
Internal and Emergency Medicine (2023) Vol. 19, Iss. 2, pp. 275-293
Open Access | Times Cited: 303

Gut microbiome, liver immunology, and liver diseases
Rui Wang, Ruqi Tang, Bo Li, et al.
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 1, pp. 4-17
Open Access | Times Cited: 299

Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction
Cornelius Engelmann, J. J. Clariá, Gyöngyi Szabó, et al.
Journal of Hepatology (2021) Vol. 75, pp. S49-S66
Open Access | Times Cited: 252

Cirrhosis-associated immune dysfunction
Agustı́n Albillos, Rosa Martín‐Mateos, Van der Merwe, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 19, Iss. 2, pp. 112-134
Open Access | Times Cited: 249

Short-chain fatty acids in diseases
Dan Zhang, Yong‐Ping Jian, Yuning Zhang, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 186

The microbiota in cirrhosis and its role in hepatic decompensation
Jonel Trebicka, Jane Macnaughtan, Bernd Schnabl, et al.
Journal of Hepatology (2021) Vol. 75, pp. S67-S81
Open Access | Times Cited: 175

The gut virome: A new microbiome component in health and disease
Zhirui Cao, Naoki Sugimura, Elke Burgermeister, et al.
EBioMedicine (2022) Vol. 81, pp. 104113-104113
Open Access | Times Cited: 161

Inflammasomes and Fibrosis
Wenjuan Zhang, Shujuan Chen, Shunchang Zhou, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 152

An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH
Frank Tacke, Tobias Puengel, Rohit Loomba, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 552-566
Closed Access | Times Cited: 152

Baicalin and the liver-gut system: Pharmacological bases explaining its therapeutic effects
Qichao Hu, Wenwen Zhang, Zhao Wu, et al.
Pharmacological Research (2021) Vol. 165, pp. 105444-105444
Closed Access | Times Cited: 147

Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure
Jonel Trebicka, Peer Bork, Aleksander Krag, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 18, Iss. 3, pp. 167-180
Closed Access | Times Cited: 145

Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy
Yasuko Iwakiri, Jonel Trebicka
JHEP Reports (2021) Vol. 3, Iss. 4, pp. 100316-100316
Open Access | Times Cited: 144

Intestinal Barrier and Permeability in Health, Obesity and NAFLD
Piero Portincasa, Leonilde Bonfrate, Mohamad Khalil, et al.
Biomedicines (2021) Vol. 10, Iss. 1, pp. 83-83
Open Access | Times Cited: 143

Enterically derived high-density lipoprotein restrains liver injury through the portal vein
Yong‐Hyun Han, Emily J. Onufer, Li‐Hao Huang, et al.
Science (2021) Vol. 373, Iss. 6553
Open Access | Times Cited: 142

Crosstalk between Oxidative Stress and Inflammatory Liver Injury in the Pathogenesis of Alcoholic Liver Disease
Yoon Mee Yang, Ye Eun Cho, Seonghwan Hwang
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 774-774
Open Access | Times Cited: 135

Visualizing transfer of microbial biomolecules by outer membrane vesicles in microbe‐host‐communication in vivo
Miriam Bittel, Patrick Reichert, Ilann Sarfati, et al.
Journal of Extracellular Vesicles (2021) Vol. 10, Iss. 12
Open Access | Times Cited: 117

Page 1 - Next Page

Scroll to top